Skip to main content
European Commission logo
Coronavirus Global R&I Collaboration Portal


Research profile

OrganoTherapeutics use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease. We screen new molecules on our proprietary human-specific minibrains which represent a model mimicking faithfully the human Parkinson’s disease pathology. OrganoTherapeutics aims at developing new drug candidates against Parkinson’s disease which are tested in state-of-the art 3D patient models. OrganoTherapeutics has developed first own proprietary drug candidates and has access to attractive libraries for further screening.
OrganoTherapeutics image
Home country
Member type
Business enterprise
Type of research activities
Applied research, Basic research, Experimental development
Fields of research
Economics and Business, Natural sciences


Email address
Postal address

Get connected!

All members of this portal are keen to explore collaboration options.

Review the member profile, explore the links provided to understand this member’s focus and then reach out to them.

If this member has posted collaboration opportunities, you can see them below and get in touch.

The portal is now open.

Join this community of researchers, publish your member profile and team up for new collaboration opportunities.

Become a member